| 000 | 01423 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515052815.0 | ||
| 264 | 0 | _c20070220 | |
| 008 | 200702s 0 0 eng d | ||
| 022 | _a1476-4687 | ||
| 024 | 7 |
_a10.1038/nature05474 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSergina, Natalia V | |
| 245 | 0 | 0 |
_aEscape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3. _h[electronic resource] |
| 260 |
_bNature _cJan 2007 |
||
| 300 |
_a437-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aFeedback, Physiological |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptor, ErbB-3 _xmetabolism |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 700 | 1 | _aRausch, Megan | |
| 700 | 1 | _aWang, Donghui | |
| 700 | 1 | _aBlair, Jimmy | |
| 700 | 1 | _aHann, Byron | |
| 700 | 1 | _aShokat, Kevan M | |
| 700 | 1 | _aMoasser, Mark M | |
| 773 | 0 |
_tNature _gvol. 445 _gno. 7126 _gp. 437-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nature05474 _zAvailable from publisher's website |
| 999 |
_c16772307 _d16772307 |
||